Seeing more of what matters
Our mission is to establish the global adoption of a new standard of precision heartcare for everyone.
About Cleerly
Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for heart disease. Through its FDA-cleared solutions driven by artificial intelligence, Cleerly supports comprehensive phenotyping of coronary artery disease, as determined from advanced noninvasive CT imaging. Cleerly’s approach is grounded in science, based on millions of images from over 40,000 patients. Led by a world-class clinical and technical team, Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway.
Our dedication to clinical accuracy
Cleerly’s technology is supported by a large body of clinical evidence and we stand behind every one of our analyses. Our accuracy is demonstrated across multiple peer-reviewed, multicenter clinical studies, including the CREDENCE and PACIFIC-1 trials as well as published performance against invasive gold standards for plaque quantification (Intravascular Ultrasound, IVUS) and plaque composition (Near-Infrared Spectroscopy, NIRS). A full list of our clinical publications is available at cleerlyhealth.com/clinical-publications.
Request Your Cleerly Demo
Contact us for a one-on-one software demonstration with a Cleerly expert to see how bringing Cleerly’s AI‑driven CCTA analysis to your organization can empower you to provide personalized treatment decisions for your patients.